Every week, The American Journal of Managed Care® recaps the week’s high managed care information, and now you possibly can hear it on our podcast, Managed Care Solid.
This week, high managed care information included the FDA’s warning in opposition to adjustments to vaccine dose schedules; lower in mammograms in the course of the first months of the pandemic; first anti-TIGIT remedy to be granted Superior Remedy designation by the FDA.
Hear above or by one in every of these podcast companies:
Learn extra concerning the tales on this podcast:
What We’re Studying: FDA Stands Agency on Dosing for COVID-19 Vaccine; Haven dissolves; Moderna will increase dose supply
Mammography screenings decreased and superior breast most cancers instances elevated within the first months of COVID-19
FDA Grants Tiragolumab Breakthrough Remedy Designation for Excessive PD-L1 NSCLC
Azacitidine has been proven to enhance total relapse-free survival in older adults with AML